Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation

NCT00307463 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 258

Last updated 2013-09-09

No results posted yet for this study

Summary

This study aims mainly to investigate the effects of two approaches to control blood pressure in hypertensive hemodialysis patients; using antihypertensive drugs versus strict volume control (by strict dietary salt restriction and persistent ultrafiltration) without using antihypertensive drugs on cardiac structure and inflammation.

Conditions

  • End-stage Renal Disease

Interventions

PROCEDURE

strict volume control policy

strict volume control by UF and dietary salt restriction

PROCEDURE

antihypertensive drugs administration

continue antihypertensive medications

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • Ercan Ok, M.D · Ege University School of Medicine Nephrology Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2006-09-30
Completion
2006-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00307463 on ClinicalTrials.gov